↓ Skip to main content

Dove Medical Press

Management of keloids and hypertrophic scars: current and emerging options

Overview of attention for article published in Clinical, Cosmetic and Investigational Dermatology, April 2013
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (92nd percentile)
  • Good Attention Score compared to outputs of the same age and source (70th percentile)

Mentioned by

news
1 news outlet
twitter
7 X users
patent
3 patents
facebook
2 Facebook pages

Citations

dimensions_citation
179 Dimensions

Readers on

mendeley
225 Mendeley
Title
Management of keloids and hypertrophic scars: current and emerging options
Published in
Clinical, Cosmetic and Investigational Dermatology, April 2013
DOI 10.2147/ccid.s35252
Pubmed ID
Authors

Gerd G Gauglitz

Abstract

In the context of growing aesthetic awareness, a rising number of patients feel disappointed with their scars and are frequently seeking help for functional and aesthetic improvement. However, excessive scarring following surgery or trauma remains difficult to improve despite a plethora of advocated treatment strategies as frequently observed in daily clinical routine. It is thus still preferable to prevent scarring by minimizing risk factors as much as possible. Hence, it remains crucial for the physician to be aware of basic knowledge of healing mechanisms and skin anatomy, as well as an appreciation of suture material and wound closure techniques to minimize the risk of postoperative scarring. Next to existing, well known prophylactic and therapeutic strategies for the improvement of excessive scarring, this article discusses emerging techniques such as intralesional cryotherapy, intralesional 5-fluorouracil, interferon, and bleomycin. Some of them have been successfully tested in well-designed trials and already have extended or may extend the current spectrum of excessive scar treatment in the near future. Innovative options such as imiquimod 5% cream, photodynamic therapy, or botulinum toxin A may also be of certain importance; however, the data currently available is too contradictory for definite recommendations.

X Demographics

X Demographics

The data shown below were collected from the profiles of 7 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 225 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 1 <1%
Belgium 1 <1%
Unknown 223 99%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 35 16%
Researcher 25 11%
Student > Master 25 11%
Student > Postgraduate 18 8%
Student > Doctoral Student 18 8%
Other 43 19%
Unknown 61 27%
Readers by discipline Count As %
Medicine and Dentistry 99 44%
Nursing and Health Professions 15 7%
Agricultural and Biological Sciences 10 4%
Biochemistry, Genetics and Molecular Biology 8 4%
Pharmacology, Toxicology and Pharmaceutical Science 6 3%
Other 21 9%
Unknown 66 29%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 19. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 30 May 2021.
All research outputs
#1,996,327
of 25,806,080 outputs
Outputs from Clinical, Cosmetic and Investigational Dermatology
#147
of 920 outputs
Outputs of similar age
#15,879
of 214,015 outputs
Outputs of similar age from Clinical, Cosmetic and Investigational Dermatology
#3
of 10 outputs
Altmetric has tracked 25,806,080 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 92nd percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 920 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 23.2. This one has done well, scoring higher than 84% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 214,015 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 92% of its contemporaries.
We're also able to compare this research output to 10 others from the same source and published within six weeks on either side of this one. This one has scored higher than 7 of them.